IBT Bioservices

IBT Bioservices is a biotechnology company founded in 2009 and headquartered in the United States. It positions itself as an integrated CRO experience uniquely tailored to help in the development of modern therapeutics. The company serves as a contract research organization (CRO) offering a comprehensive range of in vitro and in vivo services as well as products to support biomedical research and development needs.

IBT Bioservices stands out as a trusted partner for both biotech startups and established pharmaceutical companies, simplifying the development process and accelerating the journey toward bringing innovative biotherapeutics to patients in need. Its team of highly skilled scientists, researchers, and industry experts collaboratively deliver exceptional results, distinguishing the company as a one-stop shop CRO for virtual biotech companies, research institutions, and pharma companies of all sizes.

Its offerings include in vitro services such as a variety of off-the-shelf assays and in vivo services covering efficacy models against viral and bacterial infections, immunogenicity models, breeding, and vivarium services. In addition, IBT Bioservices provides a wide inventory of reagents available for purchase, including recombinant proteins, antibodies, virus-like particles, pseudoviruses, ELISA kits, and reporter cell lines, all of which can be shipped internationally.

IBT Bioservices prides itself on offering concierge-level support tailored to each client’s unique project, with capabilities for custom assay, disease model, and reagent development/production, addressing specific project needs. For more information, interested parties can contact IBT Bioservices at [email protected] or visit their website at www.IBTBioServices.com.